Product Images Fluzone High-dose Quadrivalent Southern Hemisphere
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 2 images provide visual information about the product associated with Fluzone High-dose Quadrivalent Southern Hemisphere NDC 49281-933 by Sanofi Pasteur Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PRINCIPAL DISPLAY PANEL - 0.7 mL Syringe Label - fluzone 01
This is a 0.7 mL single-dose intramuscular influenza vaccine called Fluzone High-Dose R, with a quadrivalent Southern Hemisphere 2023 formula. It is manufactured by Sanofi Pasteur Inc. and is intended for individuals aged 65 years and older. The National Drug Code is 49281-379-88. Lot and P numbers are also included.*
PRINCIPAL DISPLAY PANEL - 0.7 mL Syringe Package - fluzone 02
This is a product description for Fluzone High-Dose Quadrivalent Southern Hemisphere, an influenza vaccine produced by Sanofi Pasteur Inc. It is a single-use, intramuscular injection with 10 prefilled syringes per package. The vaccine is standardized for the 2023 flu season and contains four prototype strains of influenza virus, and has been inactivated with formaldehyde. It does not contain any preservatives or natural rubber latex. The vaccine must be stored at 2° to 8°C (35° to 46°F), and must not be frozen. Full prescribing information is available.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.